SMER 3Selective inhibitor of E3 ubiquitin ligase CAS# 67200-34-4 |
2D Structure
- BV6
Catalog No.:BCC5372
CAS No.:1001600-56-1
- LCL161
Catalog No.:BCC1691
CAS No.:1005342-46-0
- Birinapant (TL32711)
Catalog No.:BCC2250
CAS No.:1260251-31-7
- Embelin
Catalog No.:BCN2678
CAS No.:550-24-3
- GDC-0152
Catalog No.:BCC2252
CAS No.:873652-48-3
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 67200-34-4 | SDF | Download SDF |
PubChem ID | 568763 | Appearance | Powder |
Formula | C11H4N4O2 | M.Wt | 224.18 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 75 mM in DMSO | ||
SMILES | C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3C2=O | ||
Standard InChIKey | SFSSAKVWCKFRHE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H4N4O2/c16-9-6-4-2-1-3-5(6)7-8(9)13-11-10(12-7)14-17-15-11/h1-4H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective inhibitor of a yeast SCF family E3 ubiquitin ligase (SCFMet30) in vitro and in vivo. Induces the expression of MET genes; blocks cell proliferation. Enhancer of rapamycin. |
SMER 3 Dilution Calculator
SMER 3 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.4607 mL | 22.3035 mL | 44.607 mL | 89.214 mL | 111.5175 mL |
5 mM | 0.8921 mL | 4.4607 mL | 8.9214 mL | 17.8428 mL | 22.3035 mL |
10 mM | 0.4461 mL | 2.2304 mL | 4.4607 mL | 8.9214 mL | 11.1518 mL |
50 mM | 0.0892 mL | 0.4461 mL | 0.8921 mL | 1.7843 mL | 2.2304 mL |
100 mM | 0.0446 mL | 0.223 mL | 0.4461 mL | 0.8921 mL | 1.1152 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- H-HoSer-OH
Catalog No.:BCC3247
CAS No.:672-15-1
- (±)-U-50488 hydrochloride
Catalog No.:BCC6665
CAS No.:67197-96-0
- Moronic acid
Catalog No.:BCN4222
CAS No.:6713-27-5
- Yamataimine
Catalog No.:BCN2064
CAS No.:67113-69-3
- Tubotaiwine
Catalog No.:BCN4016
CAS No.:6711-69-9
- Cyclo(Pro-Pro)
Catalog No.:BCN2415
CAS No.:6708-06-1
- Datumetine
Catalog No.:BCN1930
CAS No.:67078-20-0
- Trichophydine
Catalog No.:BCN1781
CAS No.:67031-54-3
- Pepluanin A
Catalog No.:BCN4221
CAS No.:670257-89-3
- Ohchinin acetate
Catalog No.:BCN4220
CAS No.:67023-81-8
- Ohchinin
Catalog No.:BCN4601
CAS No.:67023-80-7
- Crenolanib (CP-868596)
Catalog No.:BCC3671
CAS No.:670220-88-9
- 2'-O-Coumaroyljuglanin
Catalog No.:BCN6559
CAS No.:67214-05-5
- 5'-O-Dimethoxytrityl-N-benzoyl-desoxycytidine
Catalog No.:BCC8750
CAS No.:67219-55-0
- Fenoldopam
Catalog No.:BCC4462
CAS No.:67227-56-9
- 10(14)-Cadinene-4,5-diol
Catalog No.:BCN4223
CAS No.:672336-50-4
- Boc-MLF
Catalog No.:BCC6061
CAS No.:67247-12-5
- Cabraleadiol
Catalog No.:BCN4224
CAS No.:67253-01-4
- SKF 81297 hydrobromide
Catalog No.:BCC7071
CAS No.:67287-39-2
- SKF 83959 hydrobromide
Catalog No.:BCC7251
CAS No.:67287-95-0
-
γDGG
Catalog No.:BCC6557
CAS No.:6729-55-1
- Kif15-IN-1
Catalog No.:BCC5152
CAS No.:672926-32-8
- Kif15-IN-2
Catalog No.:BCC5153
CAS No.:672926-33-9
- 3-O-(2'E ,4'Z-decadienoyl)-20-deoxyingenol
Catalog No.:BCN1382
CAS No.:672941-64-9
Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase.[Pubmed:20581845]
Nat Biotechnol. 2010 Jul;28(7):738-42.
The target of rapamycin (TOR) plays a central role in eukaryotic cell growth control. With prevalent hyperactivation of the mammalian TOR (mTOR) pathway in human cancers, strategies to enhance TOR pathway inhibition are needed. We used a yeast-based screen to identify small-molecule enhancers of rapamycin (SMERs) and discovered an inhibitor (SMER3) of the Skp1-Cullin-F-box (SCF)(Met30) ubiquitin ligase, a member of the SCF E3-ligase family, which regulates diverse cellular processes including transcription, cell-cycle control and immune response. We show here that SMER3 inhibits SCF(Met30) in vivo and in vitro, but not the closely related SCF(Cdc4). Furthermore, we demonstrate that SMER3 diminishes binding of the F-box subunit Met30 to the SCF core complex in vivo and show evidence for SMER3 directly binding to Met30. Our results show that there is no fundamental barrier to obtaining specific inhibitors to modulate function of individual SCF complexes.